Skip to Content
Merck
CN
  • Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol.

Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol.

Frontiers in pharmacology (2017-08-05)
Xiangmeng Wu, Qinghao Zhang, Jiamei Guo, Yufei Jia, Ziqian Zhang, Manman Zhao, Yakun Yang, Baolian Wang, Jinping Hu, Li Sheng, Yan Li
ABSTRACT

10-Chloromethyl-11-demethyl-12-oxo-calanolide (F18), an analog of calanolide A, is a novel potent nonnucleoside reverse transcriptase inhibitor against HIV-1. Here, we report the metabolic profile and the results of associated biochemical studies of F18

MATERIALS
Product Number
Brand
Product Description

Supelco
Flufenamic acid, analytical standard, for drug analysis
Sigma-Aldrich
2-Chloroethyl ethyl sulfide, 97%
Sigma-Aldrich
Furafylline, ≥98% (HPLC)
Sigma-Aldrich
Fomepizole, 99%